NanoViricides, Inc. ( NNVC) - Key Metrics
NNVC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0 | -$0.11 | $154,321.42 | $158,497.95 |
| 2026Q3 | $0 | -$0.09 | -$0.09 | -$0.09 |
| 2026Q2 | $0 | -$0.11 | -$0.10 | -$0.10 |
| 2026Q1 | $0 | -$0.10 | -$0.09 | -$0.10 |
| 2025Q4 | $0 | -$0.13 | -$0.10 | -$0.10 |
NNVC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -3.14 |
| 2026Q3 | 0% | -2.48 |
| 2026Q2 | 0% | -2.57 |
| 2026Q1 | 0% | -3.57 |
| 2025Q4 | 0% | -2.69 |
NNVC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 11485358.92% | 0% |
| 2026Q3 | -9.80% | 0% |
| 2026Q2 | -9.14% | 0% |
| 2026Q1 | -6.87% | 0% |
| 2025Q4 | -7.41% | 0% |
NNVC
Price: $1.35
52 week price:
Earnings Per Share: -0.41 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 10400
Market Capitalization: 33.2 million